Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.61%
1,084.50
+17.14
+1.61%
—1,067.361,073.631,085.091,073.63——
SIXC
Communications
SIXC
Communications
SIXC
-0.05%
603.20
-0.28
-0.05%
—603.48603.48606.47601.51——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,239.36
-5.57
-0.45%
—1,244.931,238.101,246.591,229.30——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.42%
1,754.99
+24.61
+1.42%
—1,730.381,737.301,755.281,737.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.20%
640.72
+1.25
+0.20%
—639.47639.46643.01639.42——
SIXR
Staples
SIXR
Staples
SIXR
-0.90%
847.23
-7.72
-0.90%
—854.95854.97855.66845.90——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.48%
219.61
+1.05
+0.48%
—218.56218.56220.16218.53——
SIXT
Technology
SIXT
Technology
SIXT
+2.14%
3,709.21
+77.62
+2.14%
—3,631.593,687.983,716.243,675.71——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.37%
919.13
+3.36
+0.37%
—915.77917.87921.16916.45——
SIXV
Health care
SIXV
Health care
SIXV
-0.78%
1,501.01
-11.80
-0.78%
—1,512.811,514.561,514.951,497.82——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.54%
2,421.16
+13.17
+0.54%
—2,408.212,418.112,427.232,410.54——
TMCI:NASDAQ
Treace Medical Concepts, Inc
$2.78
-0.18%
(-0.0050) 1D
May 26, 10:17:18 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TMCI...
Open
$2.83
High
$2.86
Low
$2.73
Mkt. cap
180.35M
Avg. vol.
576.11K
Volume
37.96K
52-wk high
$7.78
52-wk low
$1.17
EPS
-$0.96
Beta
1.11
Shares outstanding
64.87M
No. of employees
450
News stories
From sources across the web
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc
CEO-
Employees450
Founded2014
Headquarters-
SectorMedical device
Websitetreace.com
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.12 / -$0.31
+62.78%beat
Revenue / Est. (USD)
47.20M / 46.05M
+2.49%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
47.39M
50.21M
62.52M
47.20M
Cost of goods sold
9.64M
10.51M
12.12M
9.79M
Cost of revenue
9.64M
10.51M
12.12M
9.79M
Research and development expenses
5.50M
4.68M
4.54M
4.62M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49.23M
49.70M
51.78M
49.95M
Operating expense
54.73M
54.38M
56.32M
54.57M
Total operating expenses
64.36M
64.89M
68.44M
64.36M
Operating income
-16.97M
-14.68M
-5.92M
-17.17M
Other non operating income
122.00K
92.00K
88.00K
275.00K
EBT including unusual items
-17.40M
-16.29M
-9.39M
-17.96M
EBT excluding unusual items
-17.40M
-15.29M
-6.66M
-17.96M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.40M
-16.29M
-9.39M
-17.96M
Net profit margin
-36.71%
-32.44%
-15.03%
-38.05%
Earnings per share
-0.26
-0.22
-0.08
-0.12
Interest and investment income
775.00K
634.00K
527.00K
501.00K
Interest expense
-1.32M
-1.34M
-1.35M
-1.57M
Net interest expenses
-546.00K
-704.00K
-823.00K
-1.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.40M
-11.90M
-4.11M
-16.27M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer